Role of psychiatric hospitals during a pandemic: introducing the Munich Psychiatric COVID-19 Pandemic Contingency Plan.

COVID-19 Mental disorders SARS-CoV-2 infection pandemic plan psychiatric hospitals

Journal

BJPsych open
ISSN: 2056-4724
Titre abrégé: BJPsych Open
Pays: England
ID NLM: 101667931

Informations de publication

Date de publication:
01 Feb 2021
Historique:
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 2 2 2021
Statut: epublish

Résumé

Psychiatry is facing major challenges during the current coronavirus disease 2019 (COVID)-19 pandemic. These challenges involve its actual and perceived role within the medical system, in particular how psychiatric hospitals can maintain their core mission of attending to people with mental illness while at the same time providing relief to overstretched general medicine services. Although psychiatric disorders comprise the leading cause of the global burden of disease, mental healthcare has been deemphasised in the wake of the onslaught of the pandemic: to make room for emergency care, psychiatric wards have been downsized, clinics closed, psychiatric support systems discontinued and so on. To deal with this pressing issue, we developed a pandemic contingency plan with the aim to contain, decelerate and, preferably, avoid transmission of COVID-19 and to enable and maintain medical healthcare for patients with mental disorders. To describe our plan as an example of how a psychiatric hospital can share in providing acute care in a healthcare system facing an acute and highly infectious pandemic like COVID-19 and at the same time provide support for people with mental illness, with or without a COVID-19 infection. This was a descriptive study. The plan was based on the German national pandemic strategy and several legal recommendations and was implemented step by step on the basis of the local COVID-19 situation. In addition, mid- and long-term plans were developed for coping with the aftermath of the pandemic. The plan enabled the University Hospital to maintain medical healthcare for patients with mental disorders. It has offered the necessary flexibility to adapt its implementation to the first and second waves of the COVID-19 pandemic in Germany. The plan is designed to serve as an easily adaptable blueprint for psychiatric hospitals around the world.

Sections du résumé

BACKGROUND BACKGROUND
Psychiatry is facing major challenges during the current coronavirus disease 2019 (COVID)-19 pandemic. These challenges involve its actual and perceived role within the medical system, in particular how psychiatric hospitals can maintain their core mission of attending to people with mental illness while at the same time providing relief to overstretched general medicine services. Although psychiatric disorders comprise the leading cause of the global burden of disease, mental healthcare has been deemphasised in the wake of the onslaught of the pandemic: to make room for emergency care, psychiatric wards have been downsized, clinics closed, psychiatric support systems discontinued and so on. To deal with this pressing issue, we developed a pandemic contingency plan with the aim to contain, decelerate and, preferably, avoid transmission of COVID-19 and to enable and maintain medical healthcare for patients with mental disorders.
AIMS OBJECTIVE
To describe our plan as an example of how a psychiatric hospital can share in providing acute care in a healthcare system facing an acute and highly infectious pandemic like COVID-19 and at the same time provide support for people with mental illness, with or without a COVID-19 infection.
METHOD METHODS
This was a descriptive study.
RESULTS RESULTS
The plan was based on the German national pandemic strategy and several legal recommendations and was implemented step by step on the basis of the local COVID-19 situation. In addition, mid- and long-term plans were developed for coping with the aftermath of the pandemic.
CONCLUSIONS CONCLUSIONS
The plan enabled the University Hospital to maintain medical healthcare for patients with mental disorders. It has offered the necessary flexibility to adapt its implementation to the first and second waves of the COVID-19 pandemic in Germany. The plan is designed to serve as an easily adaptable blueprint for psychiatric hospitals around the world.

Identifiants

pubmed: 33517940
doi: 10.1192/bjo.2020.167
pii: S2056472420001672
pmc: PMC7853741
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e41

Références

BJPsych Open. 2020 Apr 06;6(3):e48
pubmed: 32250235
J Affect Disord. 2020 Sep 1;274:1062-1067
pubmed: 32663933
J Inflamm Res. 2021 Jan 07;14:13-56
pubmed: 33447071
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Nervenarzt. 2020 Oct 6;:
pubmed: 33025071
J Psychiatry Neurosci. 2020 Apr 03;45(4):200061
pubmed: 32242646

Auteurs

Kristina Adorjan (K)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; and Center for International Health (CIHLMU), University Hospital, LMU Munich, Germany.

Oliver Pogarell (O)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Dorothee Streb (D)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Frank Padberg (F)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Christian Erdmann (C)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Gabriele Koller (G)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Florian Raabe (F)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Daniela Reich-Erkelenz (D)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.

Sylvia de Jonge (S)

Department of Molecular Neurobiology at Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Karin Neumeier (K)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany; and Department of Molecular Neurobiology at Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Peter Zill (P)

Department of Molecular Neurobiology at Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Karl-Walter Jauch (KW)

University Hospital, LMU Munich, Germany.

Thomas G Schulze (TG)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.

Peter Falkai (P)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Classifications MeSH